Aspergillosis Withdrawn Phase 3 Trials for Anidulafungin (DB00362)

Also known as: Piedra / Aspergillosis NOS / Aspergillus infection / Aspergillus infection NOS / Aspergillus infections

IndicationStatusPhase
DBCOND0020999 (Aspergillosis)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01188759Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric SubjectsTreatment